Positron emission tomography imaging for herpes virus infection: Implications for oncolytic viral treatments of cancer (Q43658831)

25 November 2017

title

Positron emission tomography imaging for herpes virus infection: Implications for oncolytic viral treatments of cancer (English)

1 reference

positron emission tomography

25 November 2017

1 reference

1 reference

Bennett JJ

1 reference

25 November 2017

Tjuvajev J

1 reference

25 November 2017

Johnson P

1 reference

25 November 2017

Doubrovin M

1 reference

25 November 2017

Akhurst T

1 reference

25 November 2017

Malholtra S

1 reference

25 November 2017

Hackman T

1 reference

25 November 2017

Balatoni J

1 reference

25 November 2017

Finn R

1 reference

25 November 2017

Larson SM

1 reference

25 November 2017

Federoff H

1 reference

25 November 2017

Blasberg R

1 reference

25 November 2017

Fong Y

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

25 November 2017

1 reference

25 November 2017

1 reference

25 November 2017

1 reference

25 November 2017

page(s)

859-863

1 reference

Regression of established macroscopic liver metastases after in situ transduction of a suicide gene

25 November 2017

cites work

1 reference

7 January 2021

Regional 'pro-drug' gene therapy: intravenous administration of an adenoviral vector expressing the E. coli cytosine deaminase gene and systemic administration of 5-fluorocytosine suppresses growth of hepatic metastasis of colon carcinoma

1 reference

7 January 2021

Prevention of hepatic tumor metastases in rats with herpes viral vaccines and gamma-interferon

1 reference

7 January 2021

Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomas

1 reference

7 January 2021

ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents

1 reference

7 January 2021

Selective infection and cytolysis of human head and neck squamous cell carcinoma with sparing of normal mucosa by a cytotoxic herpes simplex virus type 1 (G207).

1 reference

7 January 2021

Antitumor efficacy of regional oncolytic viral therapy for peritoneally disseminated cancer

1 reference

7 January 2021

Combined therapy with chemotherapeutic agents and herpes simplex virus type 1 ICP34.5 mutant (HSV-1716) in human non-small cell lung cancer

1 reference

7 January 2021

Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography

1 reference

7 January 2021

9-[(3-[18F]-fluoro-1-hydroxy-2-propoxy)methyl]guanine ([18F]-FHPG): a potential imaging agent of viral infection and gene therapy using PET.

1 reference

7 January 2021

In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020: construction and evaluation in rodents

1 reference

7 January 2021

Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma

1 reference

7 January 2021

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

1 reference

7 January 2021

A phase I study of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator gene to a lung segment of individuals with cystic fibrosis

1 reference

7 January 2021

A general approach to the non-invasive imaging of transgenes using cis-linked herpes simplex virus thymidine kinase.

1 reference

7 January 2021

Sequence determination and genetic content of the short unique region in the genome of herpes simplex virus type 1.

1 reference

7 January 2021

Identifiers

DOI

10.1038/89991

1 reference

Dimensions Publication ID

25 November 2017

1000637303

0 references

1 reference